Report overview
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation Drugs. This report contains market size and forecasts of Opioid Induced Constipation Drugs in global, including the following market information:
Global Opioid Induced Constipation Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Opioid Induced Constipation Drugs Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Opioid Induced Constipation Drugs companies in 2022 (%)
The global Opioid Induced Constipation Drugs market was valued at US$ 2604.3 million in 2022 and is projected to reach US$ 3520.9 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
We surveyed the Opioid Induced Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Constipation Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation Drugs Market Segment Percentages, by Type, 2022 (%)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Global Opioid Induced Constipation Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioid Induced Constipation Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Constipation Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Opioid Induced Constipation Drugs revenues share in global market, 2022 (%)
Key companies Opioid Induced Constipation Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Opioid Induced Constipation Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opioid Induced Constipation Drugs, market overview.
Chapter 2: Global Opioid Induced Constipation Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Opioid Induced Constipation Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioid Induced Constipation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Opioid Induced Constipation Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
